UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No. )

 

Filed by the Registrant x

Filed by a Party other than the Registrant o

 

Check the appropriate box:

o

Preliminary Proxy Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

o

Definitive Proxy Statement

x

Definitive Additional Materials

o

Soliciting Material Pursuant to §240.14a-12

 

Transgenomic, Inc.

 (Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

x	No fee required.
o	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1	)	Title of each class of securities to which transaction applies:
	(2	)	Aggregate number of securities to which transaction applies:
	(3	)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4	)	Proposed maximum aggregate value of transaction:
	(5	)	Total fee paid:
o	Fee paid previously with preliminary materials.
o	Check box if any part of the fee is offset as provided by the Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
	(1	)	Amount previously paid:
	(2	)	Form, Schedule or Registration Statement No.:
	(3	)	Filing Party:
	(4	)	Date Filed:

 

 

TRANSGENOMIC, INC.

12325 Emmet Street

Omaha, Nebraska 68164

 

 

Notice of Adjournment of Special Meeting of Stockholders

 

October 13, 2016

 

Dear Transgenomic, Inc. Stockholder,

 

You recently received proxy materials relating to a proposal to be voted on by the stockholders of Transgenomic, Inc. (the “Company”) at a Special Meeting of Stockholders to be held October 11, 2016. This important notice is to inform you that the Special Meeting has been adjourned until October 31, 2016 at 10:00 a.m. Pacific Time, to allow stockholders additional time to exercise their voting rights by submitting their voting instructions. The adjourned meeting will be held at the offices of Paul Hastings LLP, 4747 Executive Drive, 12th Floor, San Diego, California 92121.

 

This letter was sent to you because you hold shares of the Company as of September 8, 2016, the record date for the Special Meeting, and we have not yet received your vote. Please help us avoid further adjournments, phone calls, costs and additional mailing by promptly voting your shares.

 

For the reasons set forth in the proxy materials previously mailed to you, the Board of Directors of Transgenomic, Inc. recommends that you vote “FOR” the approval of the proposal to authorize the Company’s Board of Directors to, in its discretion, amend the Company’s Third Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s common stock at a ratio of between one-for-ten to one-for-thirty, such ratio to be determined by the Company’s Board of Directors.

  

Please exercise your stockholder rights and vote today! It is important that you vote, no matter how large or small your holdings may be.

 

The proxy statement and the form of proxy card are available at www.transgenomic.com

 

 

Additional Information

The Company has retained Innisfree M&A Incorporated to assist in the solicitation of proxies for a fee of $7,500 plus out-of-pocket expenses.

 

	Sincerely yours,
	/s/ PAUL KINNON
	Paul Kinnon
	President, Chief Executive Officer and Interim Chief
	Financial Officer